CClinicalTrials.gg
Sign In
CompletedNCT04703777Updated Oct 7, 2021

Relationship Between Social Status and Use of Healthcare Services During the Confinement Period Linked to the COVID-19 Epidemic

An observational study in Covid-19, sponsored by University Hospital, Strasbourg, France. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-10-07.

Sponsored by University Hospital, Strasbourg, France · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
500
Ages
18 Years and older
Sex
All
01

Study summary

Epidemics have always affected the most disadvantaged social categories more intensely. This social inequality is expressed in the use of care and emergencies: greater frequency but also greater seriousness. Our hypothesis is that, during a period of confinement, the most disadvantaged populations are more affected by the COVID-19 infection than the rest of the population. The number of remedies is greater, as is the severity of the forms of infection.

02

Conditions studied

  • Covid-19

Browse trials for

Keywords

  • COVID-19
  • Coronavirus
  • Sars-cov-2
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 500 is above the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 966 studies on the registry; 342 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patient suspected of covid-19

Inclusion criteria

  • Male or female aged 18 or over
  • Calling center 15 from March 17 at noon and until the end of the confinement period (May 31, 2020) for one of the following reasons that may be related to COVID-19: cough, fever, rhinitis, diarrhea, pain thoracic, odynophagia, diarrhea, anosmia, ageusia, whose calling address belongs to Bas-Rhin Or
  • Supported (consultation or hospitalization) at the HUS for a COVID-19 infection and included in the COVID-HUS base and residing in the Bas-Rhin.

Exclusion criteria

Exclusion Criteria:

  • Patient under the protection of justice
  • Patient under guardianship, curatorship
  • Patient taken care of at the screening center
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
500 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Retrospective study on the relationship between social status and use of healthcare services during the confinement period linked to the COVID-19 epidemic in Bas-Rhin, France

    Time frame: Files analysed retrospectily from March 17, 2020 to May 31, 2020 will be examined]

07

Study locations

1 site
  • Adult Emergency Department - Strasbourg University Hospitals
    Strasbourg, 67091, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 7, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04703777
Lead sponsor
University Hospital, Strasbourg, France
Responsible party
Sponsor
First posted
Jan 11, 2021
Start date
Apr 4, 2020
Primary completion
Apr 4, 2021
Completion
Apr 4, 2021
Last update
Oct 7, 2021

Study contacts

Mathieu OBERLIN
study director · Adult Emergency Department - Strasbourg University Hospitals

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

COVID-19→

Other studies from this sponsor

University Hospital, Strasbourg, France

Start the discussion